- Home
- OGS vs AXSM Comparison
OGS vs AXSM Comparison
Compare OGS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGS | AXSM |
|---|---|---|
| Founded | 1906 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | OGS | AXSM |
|---|---|---|
| Price | $77.57 | $146.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 20 |
| Target Price | $82.72 | ★ $176.00 |
| AVG Volume (30 Days) | 469.7K | ★ 526.6K |
| Earning Date | 11-03-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 11.73 | N/A |
| EPS | ★ 4.27 | N/A |
| Revenue | ★ $2,368,759,000.00 | $561,263,000.00 |
| Revenue This Year | $23.59 | $66.20 |
| Revenue Next Year | $4.35 | $57.56 |
| P/E Ratio | $18.00 | ★ N/A |
| Revenue Growth | 15.06 | ★ 65.83 |
| 52 Week Low | $66.38 | $75.56 |
| 52 Week High | $83.96 | $152.94 |
Technical Indicators
Market Signals| Indicator | OGS | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 36.85 | 54.38 |
| Support Level | $76.52 | $144.13 |
| Resistance Level | $77.74 | $150.00 |
| Average True Range (ATR) | 1.31 | 4.19 |
| MACD | -0.49 | -0.81 |
| Stochastic Oscillator | 14.11 | 45.68 |
Price Performance
Historical ComparisonAbout OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.